--- "@prefix : <http://www.s-cubed.dk/AAA/V1#> .\n@prefix bd: <http://www.assero.co.uk/Tabulation#>
  .\n@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .\n@prefix isoT: <http://www.assero.co.uk/ISO11179Types#>
  .\n@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .\n@prefix isoI:
  <http://www.assero.co.uk/ISO11179Identification#> .\n@prefix bo: <http://www.assero.co.uk/BusinessOperational#>
  .\n@prefix owl: <http://www.w3.org/2002/07/owl#> .\n@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>
  .\n@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .\n@prefix xsd: <http://www.w3.org/2001/XMLSchema#>
  .\n@prefix skos: <http://www.w3.org/2004/02/skos/core#> .\n\n<http://www.s-cubed.dk/AAA/V1>\n\trdf:type
  owl:Ontology ;\n.\n:SPD\n\trdf:type bd:SdtmSponsorDomain ;\n\tisoC:label \"SDTM
  Sponsor Domain\"^^xsd:string ;\n\tisoT:hasState :SPD_RS ;\n\tisoT:hasIdentifier
  :SPD_SI ;\n\tisoT:origin \"\"^^xsd:string ;\n\tisoT:changeDescription \"\"^^xsd:string
  ;\n\tisoT:creationDate \"2020-12-15T08:19:09+01:00\"^^xsd:dateTime ;\n\tisoT:lastChangeDate
  \"2020-12-15T08:19:09+01:00\"^^xsd:dateTime ;\n\tisoT:explanatoryComment \"\"^^xsd:string
  ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"1\"^^xsd:positiveInteger ;\n\tbd:includesColumn
  :SPD_AESMIE ;\n\tbd:includesColumn :SPD_AESER ;\n\tbd:includesColumn :SPD_AEGRPID
  ;\n\tbd:includesColumn :SPD_AECAT ;\n\tbd:includesColumn :SPD_AESEV ;\n\tbd:includesColumn
  :SPD_AESCONG ;\n\tbd:includesColumn :SPD_DOMAIN ;\n\tbd:includesColumn :SPD_AESTDTC
  ;\n\tbd:includesColumn :SPD_AEENRF ;\n\tbd:includesColumn :SPD_AESOD ;\n\tbd:includesColumn
  :SPD_AECONTRT ;\n\tbd:includesColumn :SPD_AEREFID ;\n\tbd:includesColumn :SPD_AEREL
  ;\n\tbd:includesColumn :SPD_AESDISAB ;\n\tbd:includesColumn :SPD_AESCAT ;\n\tbd:includesColumn
  :SPD_AEOUT ;\n\tbd:includesColumn :SPD_AESTDY ;\n\tbd:includesColumn :SPD_AESPID
  ;\n\tbd:includesColumn :SPD_AEENRTPT ;\n\tbd:includesColumn :SPD_AEPRESP ;\n\tbd:includesColumn
  :SPD_AESHOSP ;\n\tbd:includesColumn :SPD_AETERM ;\n\tbd:includesColumn :SPD_AELOC
  ;\n\tbd:includesColumn :SPD_AEPATT ;\n\tbd:includesColumn :SPD_AESLIFE ;\n\tbd:includesColumn
  :SPD_AEDUR ;\n\tbd:includesColumn :SPD_AEDECOD ;\n\tbd:includesColumn :SPD_AEMODIFY
  ;\n\tbd:includesColumn :SPD_AESEQ ;\n\tbd:includesColumn :SPD_AERELNST ;\n\tbd:includesColumn
  :SPD_AESDTH ;\n\tbd:includesColumn :SPD_AEBODSYS ;\n\tbd:includesColumn :SPD_AEACNOTH
  ;\n\tbd:includesColumn :SPD_AETOXGR ;\n\tbd:includesColumn :SPD_AEENDY ;\n\tbd:includesColumn
  :SPD_USUBJID ;\n\tbd:includesColumn :SPD_AEENDTC ;\n\tbd:includesColumn :SPD_AEACN
  ;\n\tbd:includesColumn :SPD_AEENTPT ;\n\tbd:includesColumn :SPD_STUDYID ;\n\tbd:includesColumn
  :SPD_AESCAN ;\n\tbd:prefix \"AE\"^^xsd:string ;\n\tbd:structure \"One record per
  adverse event per subject\"^^xsd:string ;\n\tbd:basedOnClass <http://www.cdisc.org/SDTM_MODEL_EVENTS/V1#CL>
  ;\n.\n:SPD_RS\n\trdf:type isoR:RegistrationState ;\n\tisoR:registrationStatus \"Incomplete\"^^xsd:string
  ;\n\tisoR:administrativeNote \"\"^^xsd:string ;\n\tisoR:effectiveDate \"2016-01-01T00:00:00+00:00\"^^xsd:dateTime
  ;\n\tisoR:untilDate \"2016-01-01T00:00:00+00:00\"^^xsd:dateTime ;\n\tisoR:unresolvedIssue
  \"\"^^xsd:string ;\n\tisoR:administrativeStatus \"\"^^xsd:string ;\n\tisoR:previousState
  \"Incomplete\"^^xsd:string ;\n\tisoR:multipleEdit \"false\"^^xsd:boolean ;\n\tisoR:byAuthority
  <http://www.assero.co.uk/RA#DUNS123456789> ;\n.\n<http://www.assero.co.uk/RA#DUNS123456789>\n\trdf:type
  isoR:RegistrationAuthority ;\n\tisoR:organizationIdentifier \"123456789\"^^xsd:string
  ;\n\tisoR:internationalCodeDesignator \"DUNS\"^^xsd:string ;\n\tisoR:owner \"true\"^^xsd:boolean
  ;\n\tisoR:raNamespace <http://www.assero.co.uk/NS#SCUBED> ;\n.\n<http://www.assero.co.uk/NS#SCUBED>\n\trdf:type
  isoI:Namespace ;\n\tisoI:shortName \"S-cubed\"^^xsd:string ;\n\tisoI:name \"S-cubed
  Aps\"^^xsd:string ;\n\tisoI:authority \"www.s-cubed.dk\"^^xsd:string ;\n.\n:SPD_SI\n\trdf:type
  isoI:ScopedIdentifier ;\n\tisoI:identifier \"AAA\"^^xsd:string ;\n\tisoI:versionLabel
  \"\"^^xsd:string ;\n\tisoI:version \"1\"^^xsd:positiveInteger ;\n\tisoI:semanticVersion
  \"0.1.0\"^^xsd:string ;\n\tisoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;\n.\n:SPD_AESMIE\n\trdf:type
  bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Other Medically Important Serious
  Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"31\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESMIE\"^^xsd:string ;\n\tbd:description \"Do additional categories
  for seriousness apply?\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"(NY)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESMIE_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESMIE>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESMIE_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AESER\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Serious
  Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"17\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESER\"^^xsd:string ;\n\tbd:description \"Is this a serious event?\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESER_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESER>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESER_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AEGRPID\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Group
  ID\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"5\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEGRPID\"^^xsd:string ;\n\tbd:description \"Used to tie together
  a block of related records in a single domain for a subject.\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEGRPID>
  ;\n.\n:SPD_AECAT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Category
  for Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"11\"^^xsd:positiveInteger
  ;\n\tbd:name \"AECAT\"^^xsd:string ;\n\tbd:description \"Used to define a category
  of related records. Example: BLEEDING, NEUROPSYCHIATRIC.\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECAT>
  ;\n.\n:SPD_AESEV\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Severity/Intensity\"^^xsd:string
  ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"16\"^^xsd:positiveInteger ;\n\tbd:name
  \"AESEV\"^^xsd:string ;\n\tbd:description \"The severity or intensity of the event.
  Examples: MILD, MODERATE, SEVERE.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string
  ;\n\tbd:ctAndFormat \"(AESEV)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEV_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEV>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEV_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"AESEV\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66769/V4#C66769> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AESCONG\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Congenital
  Anomaly or Birth Defect\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"25\"^^xsd:positiveInteger ;\n\tbd:name \"AESCONG\"^^xsd:string ;\n\tbd:description
  \"Was the serious event associated with congenital anomaly or birth defect?\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCONG_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCONG>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCONG_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_DOMAIN\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Domain
  Abbreviation\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"2\"^^xsd:positiveInteger
  ;\n\tbd:name \"DOMAIN\"^^xsd:string ;\n\tbd:description \"Two-character abbreviation
  for the domain.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_DOMAIN>
  ;\n.\n:SPD_AESTDTC\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Start
  Date/Time of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"34\"^^xsd:positiveInteger ;\n\tbd:name \"AESTDTC\"^^xsd:string ;\n\tbd:description
  \"\"^^xsd:string ;\n\tbd:format \"ISO 8601\"^^xsd:string ;\n\tbd:ctAndFormat \"ISO
  8601\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESTDTC>
  ;\n.\n:SPD_AEENRF\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"End
  Relative to Reference Period\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"39\"^^xsd:positiveInteger ;\n\tbd:name \"AEENRF\"^^xsd:string ;\n\tbd:description
  \"Describes the end of the event relative to the sponsor-defined reference period.
  The sponsor-defined reference period is a continuous period of time defined by a
  discrete starting point (RFSTDTC) and a discrete ending point (RFENDTC) of the trial.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(STENRF)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRF_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRF>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRF_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"STENRF\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66728/V4#C66728> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AESOD\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Occurred
  with Overdose\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"30\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESOD\"^^xsd:string ;\n\tbd:description \"Did the serious event occur
  with an overdose?\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"(NY)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESOD_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESOD>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESOD_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AECONTRT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Concomitant
  or Additional Trtmnt Given\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"32\"^^xsd:positiveInteger ;\n\tbd:name \"AECONTRT\"^^xsd:string ;\n\tbd:description
  \"Was another treatment given because of the occurrence of the event?\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECONTRT_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECONTRT>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECONTRT_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AEREFID\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Reference
  ID\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"6\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEREFID\"^^xsd:string ;\n\tbd:description \"Internal or external
  identifier such as a serial number on an SAE reporting form\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEREFID>
  ;\n.\n:SPD_AEREL\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Causality\"^^xsd:string
  ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"20\"^^xsd:positiveInteger ;\n\tbd:name
  \"AEREL\"^^xsd:string ;\n\tbd:description \"Records the investigator's opinion as
  to the causality of the event to the treatment. ICH E2A and E2B examples include
  NOT RELATED, UNLIKELY RELATED, POSSIBLY RELATED, RELATED. Controlled Terminology
  may be defined in the future. Check with regulatory authority for population of
  this variable\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEREL>
  ;\n.\n:SPD_AESDISAB\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Persist
  or Signif Disability/Incapacity\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"26\"^^xsd:positiveInteger ;\n\tbd:name \"AESDISAB\"^^xsd:string ;\n\tbd:description
  \"Did the serious event result in persistent or significant disability/incapacity?\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDISAB_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDISAB>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDISAB_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AESCAT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Subcategory
  for Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"12\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESCAT\"^^xsd:string ;\n\tbd:description \"A further categorization
  of adverse event. Example: NEUROLOGIC.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string
  ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAT>
  ;\n.\n:SPD_AEOUT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Outcome
  of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"23\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEOUT\"^^xsd:string ;\n\tbd:description \"Description of the outcome
  of an event.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(OUT)\"^^xsd:string
  ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEOUT_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEOUT>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEOUT_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"OUT\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66768/V4#C66768> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AESTDY\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Study
  Day of Start of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"36\"^^xsd:positiveInteger ;\n\tbd:name \"AESTDY\"^^xsd:string ;\n\tbd:description
  \"Study day of start of adverse event relative to the sponsor-defined RFSTDTC.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESTDY>
  ;\n.\n:SPD_AESPID\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Sponsor-Defined
  Identifier\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"7\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESPID\"^^xsd:string ;\n\tbd:description \"Sponsor-defined identifier.
  It may be pre-printed on the CRF as an explicit line identifier or defined in the
  sponsor's operational database. Example: Line number on an Adverse Events page.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESPID>
  ;\n.\n:SPD_AEENRTPT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"End
  Relative to Reference Time Point\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"40\"^^xsd:positiveInteger ;\n\tbd:name \"AEENRTPT\"^^xsd:string ;\n\tbd:description
  \"Identifies the end of the event as being before or after the reference time point
  defined by variable AEENTPT.\"^^xsd:string ;\n\tbd:format \"BEFORE, AFTER, COINCIDENT,
  ONGOING, U\"^^xsd:string ;\n\tbd:ctAndFormat \"BEFORE, AFTER, COINCIDENT, ONGOING,
  U\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRTPT>
  ;\n.\n:SPD_AEPRESP\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Pre-Specified
  Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"13\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEPRESP\"^^xsd:string ;\n\tbd:description \"A value of 'Y' indicates
  that this adverse event was pre-specified on the CRF. Values are null for spontaneously
  reported events (i.e., those collected as free-text verbatim terms)\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPRESP_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPRESP>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPRESP_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AESHOSP\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Requires
  or Prolongs Hospitalization\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"28\"^^xsd:positiveInteger ;\n\tbd:name \"AESHOSP\"^^xsd:string ;\n\tbd:description
  \"Did the serious event require or prolong hospitalization?\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESHOSP_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESHOSP>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESHOSP_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AETERM\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Reported
  Term for the Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"8\"^^xsd:positiveInteger ;\n\tbd:name \"AETERM\"^^xsd:string ;\n\tbd:description
  \"Verbatim name of the event.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AETERM>
  ;\n.\n:SPD_AELOC\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Location
  of Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"15\"^^xsd:positiveInteger
  ;\n\tbd:name \"AELOC\"^^xsd:string ;\n\tbd:description \"Describes anatomical location
  relevant for the event (e.g., LEFT ARM for skin rash).\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(LOC)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AELOC_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AELOC>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AELOC_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"LOC\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C74456/V8#C74456> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AEPATT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Pattern
  of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"22\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEPATT\"^^xsd:string ;\n\tbd:description \"Used to indicate the pattern
  of the event over time. Examples: INTERMITTENT, CONTINUOUS, SINGLE EVENT.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPATT>
  ;\n.\n:SPD_AESLIFE\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Is
  Life Threatening\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"29\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESLIFE\"^^xsd:string ;\n\tbd:description \"Was the serious event
  life threatening?\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"(NY)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESLIFE_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESLIFE>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESLIFE_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AEDUR\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Duration
  of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"38\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEDUR\"^^xsd:string ;\n\tbd:description \"Collected duration and
  unit of an adverse event. Used only if collected on the CRF and not derived from
  start and end date/times. Example: P1DT2H (for 1 day, 2 hours).\"^^xsd:string ;\n\tbd:format
  \"ISO 8601\"^^xsd:string ;\n\tbd:ctAndFormat \"ISO 8601\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEDUR>
  ;\n.\n:SPD_AEDECOD\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Dictionary-Derived
  Term\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"10\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEDECOD\"^^xsd:string ;\n\tbd:description \"Dictionary-derived text
  description of AETERM or AEMODIFY. Equivalent to the Preferred Term (PT in MedDRA).
  The sponsor is expected to provide the dictionary name and version used to map the
  terms utilizing the define.xml external codelist attributes\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEDECOD>
  ;\n.\n:SPD_AEMODIFY\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Modified
  Reported Term\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"9\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEMODIFY\"^^xsd:string ;\n\tbd:description \"If AETERM is modified
  to facilitate coding, then AEMODIFY will contain the modified text.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEMODIFY>
  ;\n.\n:SPD_AESEQ\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Sequence
  Number\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"4\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESEQ\"^^xsd:string ;\n\tbd:description \"Sequence Number given to
  ensure uniqueness of subject records within a domain. May be any valid number.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEQ>
  ;\n.\n:SPD_AERELNST\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Relationship
  to Non-Study Treatment\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"21\"^^xsd:positiveInteger ;\n\tbd:name \"AERELNST\"^^xsd:string ;\n\tbd:description
  \"Records the investigator's opinion as to whether the event may have been due to
  a treatment other than study drug. May be reported as free text. Example: 'MORE
  LIKELY RELATED TO ASPIRIN USE.'.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AERELNST>
  ;\n.\n:SPD_AESDTH\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Results
  in Death\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"27\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESDTH\"^^xsd:string ;\n\tbd:description \"Did the serious event
  result in death?\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat
  \"(NY)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDTH_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDTH>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDTH_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AEBODSYS\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Body
  System or Organ Class\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"14\"^^xsd:positiveInteger ;\n\tbd:name \"AEBODSYS\"^^xsd:string ;\n\tbd:description
  \"Dictionary derived. Body system or organ class used by the sponsor from the coding
  dictionary (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this
  should contain the SOC used for the sponsor's analyses and summary tables which
  may not necessarily be the primary SOC.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string
  ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEBODSYS>
  ;\n.\n:SPD_AEACNOTH\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Other
  Action Taken\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"19\"^^xsd:positiveInteger
  ;\n\tbd:name \"AEACNOTH\"^^xsd:string ;\n\tbd:description \"Describes other actions
  taken as a result of the event that are unrelated to dose adjustments of study treatment.
  Usually reported as free text. Example: 'TREATMENT UNBLINDED. PRIMARY CARE PHYSICIAN
  NOTIFIED.'\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string
  ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACNOTH>
  ;\n.\n:SPD_AETOXGR\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Standard
  Toxicity Grade\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"33\"^^xsd:positiveInteger
  ;\n\tbd:name \"AETOXGR\"^^xsd:string ;\n\tbd:description \"Toxicity grade according
  to a standard toxicity scale such as Common Terminology Criteria for Adverse Events
  v3.0 (CTCAE). Sponsor should specify name of the scale and version used in the metadata
  (see 6.2.1.1, Assumption 6c). If value is from a numeric scale, represent only the
  number (e.g., '2' and not 'Grade 2').\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string
  ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AETOXGR>
  ;\n.\n:SPD_AEENDY\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Study
  Day of End of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"37\"^^xsd:positiveInteger ;\n\tbd:name \"AEENDY\"^^xsd:string ;\n\tbd:description
  \"Study day of end of event relative to the sponsor-defined RFSTDTC.\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENDY>
  ;\n.\n:SPD_USUBJID\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Unique
  Subject Identifier\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"3\"^^xsd:positiveInteger
  ;\n\tbd:name \"USUBJID\"^^xsd:string ;\n\tbd:description \"Identifier used to uniquely
  identify a subject across all studies for all applications or submissions involving
  the product.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string
  ;\n\tbd:compliance <http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_USUBJID>
  ;\n.\n:SPD_AEENDTC\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"End
  Date/Time of Adverse Event\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"35\"^^xsd:positiveInteger ;\n\tbd:name \"AEENDTC\"^^xsd:string ;\n\tbd:description
  \"\"^^xsd:string ;\n\tbd:format \"ISO 8601\"^^xsd:string ;\n\tbd:ctAndFormat \"ISO
  8601\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENDTC>
  ;\n.\n:SPD_AEACN\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Action
  Taken with Study Treatment\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"18\"^^xsd:positiveInteger ;\n\tbd:name \"AEACN\"^^xsd:string ;\n\tbd:description
  \"Describes changes to the study treatment as a result of the event. AEACN is specifically
  for the relationship to study treatment. AEACNOTH is for actions unrelated to dose
  adjustments of study treatment. Examples of AEACN values include ICH E2B values:
  DRUG WITHDRAWN, DOSE REDUCED, DOSE INCREASED, DOSE NOT CHANGED, UNKNOWN or NOT APPLICABLE\"^^xsd:string
  ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"(ACN)\"^^xsd:string ;\n\tbd:compliance
  <http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4> ;\n\tbd:ctReference
  <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACN_TMC1> ;\n\tbd:comment \"\"^^xsd:string
  ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string ;\n\tbd:method
  \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACN>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACN_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"ACN\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66767/V4#C66767> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n.\n:SPD_AEENTPT\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"End
  Reference Time Point\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal
  \"41\"^^xsd:positiveInteger ;\n\tbd:name \"AEENTPT\"^^xsd:string ;\n\tbd:description
  \"Description of date/time in ISO 8601 character format of the reference point referred
  to by AEENRTPT. Examples: '2003-12-25' or 'VISIT 2'.\"^^xsd:string ;\n\tbd:format
  \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENTPT>
  ;\n.\n:SPD_STUDYID\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Study
  Identifier\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"1\"^^xsd:positiveInteger
  ;\n\tbd:name \"STUDYID\"^^xsd:string ;\n\tbd:description \"Unique identifier for
  a study.\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string ;\n\tbd:ctAndFormat \"\"^^xsd:string
  ;\n\tbd:compliance <http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c>
  ;\n\tbd:comment \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes
  \"\"^^xsd:string ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_STUDYID>
  ;\n.\n:SPD_AESCAN\n\trdf:type bd:SdtmSponsorDomainVariable ;\n\tisoC:label \"Involves
  Cancer\"^^xsd:string ;\n\tbd:rule \"\"^^xsd:string ;\n\tbd:ordinal \"24\"^^xsd:positiveInteger
  ;\n\tbd:name \"AESCAN\"^^xsd:string ;\n\tbd:description \"Was the serious event
  associated with the development of cancer?\"^^xsd:string ;\n\tbd:format \"\"^^xsd:string
  ;\n\tbd:ctAndFormat \"(NY)\"^^xsd:string ;\n\tbd:compliance <http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d>
  ;\n\tbd:ctReference <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAN_TMC1> ;\n\tbd:comment
  \"\"^^xsd:string ;\n\tbd:used \"true\"^^xsd:boolean ;\n\tbd:notes \"\"^^xsd:string
  ;\n\tbd:method \"\"^^xsd:string ;\n\tbd:basedOnIgVariable <http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAN>
  ;\n.\n<http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAN_TMC1>\n\trdf:type bo:TMcReference
  ;\n\tisoC:label \"NY\"^^xsd:string ;\n\tbo:enabled \"true\"^^xsd:boolean ;\n\tbo:optional
  \"false\"^^xsd:boolean ;\n\tbo:ordinal \"1\"^^xsd:positiveInteger ;\n\tbo:reference
  <http://www.cdisc.org/C66742/V4#C66742> ;\n\tbo:context <http://www.cdisc.org/CT/V13#TH>
  ;\n."
